| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |